the effect of zolpidem and lorazepam on the severity

Comparison effect of zolpidem and lorazepam on the severity of insomnia in methadone maintenance patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015081021309N2

Enrollment

Registered

2015-10-08

Start date

2015-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe insomnia. Neurotic, stress-related and somatoform disorders

Interventions

Intervention 1: Interventiom Group: 30 Paitions Name of consumer: Zolpidem Dosage: 10 mg Time consumption: 2 weeks. Intervention 2: Control Group: 30 Paitions Name of consumer: Lorazepam Dosage: 2 mg

Treatment - Drugs

Interventiom Group: 30 Paitions Name of consumer: Zolpidem Dosage: 10 mg Time consumption: 2 weeks

Control Group: 30 Paitions Name of consumer: Lorazepam Dosage: 2 mg Time consumption: 2 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: All addict patients treated with methadone and with severe insomnia Exclusion criteria: Medical and psychiatric illness that causes sleep disorders are serious. Use other hypnotic drugs before or during the study. Change the dose of methadone

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Insomnia. Timepoint: at the begining of study. Method of measurement: ISI Insomnia Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammad Zaman Kamkar

Golestan Research Center of Psychiatry

Dr.kamkar@goums.ac.ir+98 17 3232 5581

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026